Symeres appoints Henning Steinhagen as CEO to drive next phase of global growth

Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector

WHO rolls out new TB testing toolkit to bring diagnosis closer to patients

FUJIFILM Biosciences & NextCell launch platform to standardize regenerative medicine development

The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows

NIPER, Raebareli signs technology transfer pact with Lofty Laboratories

Academia-industry partnership to promote indigenous technology commercialization in biotech sector

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals

Lupin Q4 FY26 PBT jumps 115% to Rs 19,280 million

U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit

Roche moves to acquire PathAI for up to $1.05 billion in major AI pathology push

The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities

Uttar Pradesh poised to become India’s premier healthcare and medical device hub: Dr. G.N. Singh

Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state

Moderna’s mRNA flu vaccine outperforms standard shot in Phase 3 trial

NEJM study shows strong protection across strains

MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies

The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy